We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79B
AUM Growth
+$5.52B
(+7.5%)
Cap. Flow
-$7.01B
Cap. Flow
% of AUM
-8.87%
Top 10 Holdings %
Top 10 Hldgs %
24.46%
Holding
2,559
New
284
Increased
737
Reduced
832
Closed
260
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$555M |
| 2 |
American Electric Power
AEP
|
+$272M |
| 3 |
Ulta Beauty
ULTA
|
+$161M |
| 4 |
CVS Health
CVS
|
+$160M |
| 5 |
McDonald's
MCD
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$388M |
| 2 |
Aon
AON
|
+$211M |
| 3 |
Johnson & Johnson
JNJ
|
+$209M |
| 4 |
Norfolk Southern
NSC
|
+$162M |
| 5 |
Envista
NVST
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.99% |
| 2 | Financials | 14.12% |
| 3 | Healthcare | 13.38% |
| 4 | Industrials | 11.48% |
| 5 | Consumer Discretionary | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRX
576
Gabelli Healthcare & Wellness Trust
GRX
$144M
| $3.9M | ﹤0.01% |
417,507
| – | – |
|
577
Morgan Stanley
MS
$336B
| $3.86M | ﹤0.01% |
41,395
+477
| +1% | +$38.2K |
|
578
Idexx Laboratories
IDXX
$46.5B
| $3.79M | ﹤0.01% |
6,838
-1,184
| -15% | -$556K |
|
579
Vanguard S&P 500 Value ETF
VOOV
$6.68B
| $3.78M | ﹤0.01% |
22,526
-2,061
| -8% | -$320K |
|
580
MakeMyTrip
MMYT
$5.65B
| $3.76M | ﹤0.01% |
80,123
-9,438
| -11% | -$398K |
|
581
Edwards Lifesciences
EW
$51.5B
| $3.76M | ﹤0.01% |
49,372
-190,763
| -79% | -$13.3M |
|
582
Ovintiv
OVV
$16.6B
| $3.75M | ﹤0.01% |
85,503
+36,602
| +75% | +$1.67M |
|
583
W.P. Carey
WPC
$16.4B
| $3.75M | ﹤0.01% |
57,951
+44,803
| +341% | +$2.58M |
|
584
Arista Networks
ANET
$242B
| $3.75M | ﹤0.01% |
63,656
-23,192
| -27% | -$1.22M |
|
585
Alnylam Pharmaceuticals
ALNY
$28.9B
| $3.73M | ﹤0.01% |
19,504
+3,673
| +23% | +$626K |
|
586
Recursion Pharmaceuticals
RXRX
$1.69B
| $3.66M | ﹤0.01% |
371,699
+36,675
| +11% | +$262K |
|
587
Dick's Sporting Goods
DKS
$17.8B
| $3.65M | ﹤0.01% |
+24,814
| New | +$3.02M |
|
588
Dynatrace
DT
$14.2B
| $3.61M | ﹤0.01% |
65,943
-1,333
| -2% | -$67.4K |
|
|
AGNT
589
AGNT Inc
AGNT
$690M
| $3.6M | ﹤0.01% |
232,318
+44,288
| +24% | +$619K |
|
590
Evolent Health
EVH
$404M
| $3.59M | ﹤0.01% |
+108,632
| New | +$3.07M |
|
591
Public Service Enterprise Group
PEG
$37.4B
| $3.57M | ﹤0.01% |
58,399
+3,168
| +6% | +$195K |
|
|
INN
592
Summit Hotel Properties
INN
$724M
| $3.57M | ﹤0.01% |
530,675
-14,467
| -3% | -$89K |
|
593
W.R. Berkley
WRB
$26.8B
| $3.54M | ﹤0.01% |
75,087
+48,364
| +181% | +$2.2M |
|
594
iShares Russell 2000 ETF
IWM
$82.1B
| $3.54M | ﹤0.01% |
17,622
+11,083
| +169% | +$1.99M |
|
595
Palantir
PLTR
$375B
| $3.48M | ﹤0.01% |
202,800
+159,372
| +367% | +$2.84M |
|
596
CrowdStrike
CRWD
$211B
| $3.48M | ﹤0.01% |
54,488
-25,540
| -32% | -$1.34M |
|
597
iShares Core S&P Total US Stock Market ETF
ITOT
$97.1B
| $3.46M | ﹤0.01% |
32,865
| – | – |
|
598
Omnicell
OMCL
$1.64B
| $3.46M | ﹤0.01% |
91,842
+16,869
| +23% | +$620K |
|
599
Royce Value Trust
RVT
$2.27B
| $3.45M | ﹤0.01% |
236,857
| – | – |
|
600
Arcosa
ACA
$7.12B
| $3.44M | ﹤0.01% |
41,598
-3,692
| -8% | -$271K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Lazard Asset Management held 2,559 positions worth $79B, up 7.5% from $73.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $7.01B in Q4 2023, closing 260 positions and reducing 832 holdings. Its most notable exit was VMware, Inc, an estimated $34.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in Dentsply Sirona worth $141M.
- Lazard Asset Management's largest Q4 2023 buy was Dentsply Sirona: 3,954,444 shares worth $141M.
- Lazard Asset Management added most to Chubb in Q4 2023, an estimated $555M increase.
- Lazard Asset Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $388M.
- Lazard Asset Management fully exited VMware, Inc in Q4 2023, selling an estimated $34.5M.
- Lazard Asset Management's ten largest holdings make up 24% of its $79B portfolio in Q4 2023.
- Lazard Asset Management opened 284 new positions and closed 260 in Q4 2023.
- Lazard Asset Management's portfolio value rose 7.5% quarter-over-quarter to $79B.
Based on Lazard Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.